Cardiovascular disease. Does inflammation cut to the heart of the matter?
Taubes
Gary
G
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D005075:Biological Evolution; D015415:Biomarkers; D015992:Body Mass Index; D002097:C-Reactive Protein / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D003324:Coronary Artery Disease / Q000209:etiology* / Q000378:metabolism; D003327:Coronary Disease / Q000209:etiology / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D004730:Endothelium, Vascular / Q000166:cytology / Q000378:metabolism; D005260:Female; D006801:Humans; D007249:Inflammation; D008099:Liver / Q000378:metabolism; D008297:Male; D012307:Risk Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000924:Anticholesteremic Agents; D015415:Biomarkers; D016207:Cytokines; D002097:C-Reactive Protein; D002784:Cholesterol; D001241:Aspirin